SMTL ID : 9f2i.1 (3 other biounits)

Crystal structure of SARS-CoV-2 N-protein C-terminal domain in complex with 2-amino-1,3-benzothiazol-6-ol

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.45 Å

Oligo State

homo-dimer

Ligands

1 x 01: 2-amino-1,3-benzothiazol-6-ol

01.1: 8 residues within 4Å: Chain A: R.6, Q.7, T.29, W.77 Chain B: M.64, A.83, I.84, K.85 5 PLIP interactions: 3 interactions with chain A, 2 interactions with chain B Hydrophobic interactions: A:W.77, B:K.85 Water bridges: A:T.29 pi-Cation interactions: A:R.6 Hydrogen bonds: B:K.85

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 2 residues within 4Å: Chain A: R.6, R.9 4 PLIP interactions: 4 interactions with chain A Water bridges: A:R.9, A:R.9 Salt bridges: A:R.6, A:R.9

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 4 residues within 4Å: Chain A: Q.28, W.77, T.79 Chain B: A.83 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.28, A:W.77

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Marquez-Monino, M.A. et al., The ALS drug riluzole binds to the C-terminal domain of SARS-CoV-2 nucleocapsid protein and has antiviral activity. Structure (2024)

Release Date

2024-11-13

Peptides

Nucleoprotein: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Nucleoprotein

Related Entries With Identical Sequence